Additionally, we identify two key upstream regulatory mechanisms: METTL3 enhances LINC02418 stability via m6A modification, explaining its overexpression in CRC, and YBX1 acts both as an RBP and a transcription factor, directly promoting LINC02418 transcription. Here, METTL3 is linked to colorectal carcinoma.